Eli Lilly: This Breakout Rally Has More Room To Run

Eli Lilly stock has regained all-time highs, outpacing rivals in the obesity drug market. Click here to read my latest ...

Eli Lilly drops CVS drug plan for workers after Novo obesity deal, Bloomberg News reports

Eli Lilly is dropping CVS Health's drug benefit plan for its employees after CVS stopped covering its weight-loss drug in ...

Eli Lilly's next generation weight loss drug shows promise, early trial results suggest

Early results of Eli Lilly’s next generation of weight loss drugs appear to show promise, possibly leading to even faster ...
Fierce Pharma

Eli Lilly, Novo Nordisk strike deals with White House to cut prices of weight loss drugs

Eli Lilly and Novo Nordisk have become the latest pharma giants to strike price-reduction deals with the White House, agreeing to sell their weight loss drugs at cut-rate prices to patients in the U.S ...

Novo Nordisk cuts Wegovy, Ozempic direct-to-user prices to match Eli Lilly’s Zepbound

Novo Nordisk cuts obesity drug prices to compete with Eli Lilly, offering new patient deals and nationwide access.

Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

Trump rolls out pricing deal with weight-loss-drug giants Eli Lilly, Novo Nordisk. Analysts say the pact raises more questions than it answers.

The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims ...

Eli Lilly weight-loss drug appears to suppress binge-eating signal, small study finds

Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 ...